tiprankstipranks
Trending News
More News >
iX Biopharma Ltd. (SG:42C)
SGX:42C
Singapore Market

iX Biopharma Ltd. (42C) Cash flow

Compare
10 Followers

iX Biopharma Ltd. Cash Flow

SG:42C's free cash flow for Q4 2024 was S$-1.87M. For the 2024 fiscal year, SG:42C's free cash flow was decreased by S$2.88M and operating cash flow was S$-1.79M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
S$ -3.76MS$ -6.55MS$ -7.66MS$ 3.12MS$ -8.35M
Investing Cash Flow
S$ -201.00KS$ 1.06MS$ -695.00KS$ -5.62MS$ -507.00K
Financing Cash Flow
S$ 3.12MS$ 724.00KS$ 1.42MS$ 9.79MS$ 10.02M
End Cash Position
S$ 326.00KS$ 1.15MS$ 5.93MS$ 12.91MS$ 5.58M
Free Cash Flow
S$ -3.96MS$ -6.84MS$ -8.36MS$ 2.92MS$ -8.90M
Currency in SGD

iX Biopharma Ltd. Cash Flow